510(k) K001352
K001352 is an FDA 510(k) premarket notification submitted by Corgenix, Inc. for the device "REAADS IGG ANTI-PROTHROMBIN SEMI-QUANTITATIVE TEST KIT". The FDA issued a decision of Substantially Equivalent on April 9, 2001. The device falls under product code DHC (System, Test, Systemic Lupus Erythematosus), a Class II device regulated under 21 CFR 866.5820. Corgenix, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 9, 2001
- Date Received
- April 28, 2000
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Systemic Lupus Erythematosus
- Device Class
- Class II
- Regulation Number
- 866.5820
- Review Panel
- IM
- Submission Type